PATENT CLAIM ANALYSIS

Application Number: 15873762
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "282000"]

Abstract:
Methods are provided for attenuating or preventing μ-opioid receptor mediated tolerance and opioid-induced hyperalgesia in a subject in need of acute or chronic opioid treatment for pain or in need of opioid anesthesia.

Claim (Index 8):
The composition of  claim 7 , comprising an agonist that is selected from the group consisting of morphine, fentanyl, fentanyl analog, methadone, buprenorphine, oxycodone, and hydromorphone, and comprising an antagonist that is selected from the group consisting of methylnaltrexone (bromide) and naloxegol.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.30769
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10319789', '13560620', '13189954', '14246847', '13076386']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7835162711076967
- 35 USC 102 Novelty (BERT): 0.5480431416819254
- Combined Prediction Score: 0.7599689581651196
- Mean Citation Score: 344.695056
- Max Citation Score: 414.39047
- Similarity Product: 329.26743459016143

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test